Advanced Filters
noise
Found 1,274 clinical trials
W Wing Sze Ho, M.Sc

rTMS Response Trajectories in Depression

Notwithstanding the cumulative evidence on the safety and efficacy of transcranial magnetic stimulation in depression care, the non-response rate to transcranial magnetic stimulation (TMS) amongst treatment-resistant depression has remained substantial despite the health care cost and time incurred. There remains a compelling clinical need to find valid biomarkers to inform …

18 - 64 years of age All Phase N/A

Telephone Support vs. Self-guidance in an Internet-based Self-administered Psychological Program to Address Depression

Depression is a first level problem that poses a challenge for Primary Care (PC). The overload of care in this area requires lower-cost and more accessible alternatives. Internet-based self-applied cognitive behavioral treatments (CBCT) have demonstrated their efficacy and added advantages. The "Smiling is fun" program has been validated in Spanish …

18 - 65 years of age All Phase N/A
P Pamela González, Bachelor of Psychology

Feasibility and Acceptability Trial of a Short Term Mentalization Based Treatment for Adolescents With Depression

A feasibility pilot trial that aims to evaluate the acceptability and feasibility of mentalization-based treatment for adolescents (MBT-A) adapted for early adolescents diagnosed with depression.

10 - 14 years of age All Phase N/A
T Teresa Victor, PhD

Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression

This study aims to determine whether a keto-like supplement relative to placebo results in functional brain changes during fMRI tasks evaluating positive and negative valence in individuals with moderate to severe depression. In this double-blind randomized placebo-controlled trial, 75 individuals with a Patient Health Questionnaire (PHQ-9) scale score ≥ 10 …

18 - 65 years of age All Phase 2
K Kate R Kuhlman

Positive Affect Treatment for Adolescents With Early Life Adversity

Youth exposed to early life adversity (ELA) are known to be at greater risk for depression and suicidality and account for almost half of the youth suffering from psychiatric diseases today. Youth exposed to ELA consistently report symptoms of anhedonia as well as dysregulated positive affect. The present project will …

12 - 16 years of age All Phase N/A
A Anne Sofie Kvist Houby, MD

The Advance Project - Advancing Sleep Timing to Improve Depression

150 patients with moderate to severe depression, recently discharged from a psychiatric ward and now recieving treatment at an outpatient unit at Mental Health Center Copenhagen, will be randomised in to two groups. A treatment ad usual (TAU) group and an Advance-group. The Advance-group will receive a psychotherapeutic intervention focusing …

18 years of age All Phase N/A
M Melker Hagsäter

VGR Accelerated TMS Treatment for Depression

Intermittent theta burst stimulation (iTBS), a variant of repetitive transcranial magnetic stimulation (rTMS), is a well documented method for treatment of depression. The aim of the study is to assess the effect of an accelerated iTBS protocol compared to a routine iTBS protocol. In the accelerated protocol patients will receive …

18 years of age All Phase N/A
A Anthony Wade

Cognitive Behavioral and Faith Fellowship to Improve Thy Health

Investigators will examine the efficacy of a faith-based depression intervention, in reducing symptoms of depression among African American adults in Wisconsin. Twelve church groups, each with 10 people (N=120) will be invited to participate. This intervention will be the first evidence-based, faith-based intervention designed for African Americans if validated.

18 years of age All Phase N/A

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

This study aims to identify how enhanced allopregnanolone activity (via pregnenolone) affects behavior and neurobiology that may underlie perimenopausal depression.

40 - 60 years of age Female Phase N/A
y yan zhan, doctor

Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole

This randomized, single-blind (assessor-blind) controlled trial aims to investigate the efficacy of aripiprazole as an augmentation strategy for treating pathological rumination in patients with major depressive disorder (MDD). Pathological rumination-defined as repetitive, intrusive, and uncontrollable negative thinking-has been identified as a major transdiagnostic risk factor for the development, maintenance, and …

18 - 45 years of age All Phase N/A

Simplify language using AI